We’re super excited to announce that Patientory won the 1st grant prize for the Psoriatic Arthritis (PsA) Open Innovation Challenge organized by Novartis.
We were awarded for our unique approach of using blockchain to share health information between patients and providers to enable better tracking of symptoms and disease progression for a disease that waxes and wanes. Enabling more seamless virtual communication between patients and providers is increasingly important, especially in the current COVID Pandemic!
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals, and eye care. Novartis has leading positions globally in each of these areas. In 2017, the Group achieved net sales of USD 49.1 billion, while R&D throughout the Group amounted to approximately USD 9.0 billion. Novartis Group companies employ approximately 124,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world.
Patientory empowers healthcare systems, providers, and consumers with a single, secure application for sharing healthcare data, providing unprecedented insight into each patient’s health and resulting in better, healthier outcomes. Patientory’s applications provide increased insight into an individual’s health management and empower people to make better decisions, coordinate between care providers, and receive better care overall.